MoneyWorks4Me

Indrayani Biotech informs about disclosure

20 Sep 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, BSE has issued In-principle approval vide Ref: LOD/RIGHT/TT/FIP/920/2025-26 dated 19th September, 2025 for the proposed Right Issue; Indrayani Biotech has informed that the In-principle approval letter received from the Stock Exchange BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Grasim Industries 2865.50
DCM Shriram 953.20
3M India 30307.30
Hindustan Foods 571.45
Balmer Lawrie & Co 157.25
View more..